Product Code: ETC380518 | Publication Date: Jul 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Kazakhstan bone grafts and substitutes market is expected to experience significant growth during the forecast period (2020-2030). This market is mainly driven by the increasing number of orthopedic surgeries, rising geriatric population base, increasing prevalence of chronic musculoskeletal disorders, growing awareness about advanced treatment procedures such as autologous and allogenic bone grafting, presence of favorable reimbursement policies in the public healthcare system, etc. Additionally, technological advancements in bone substitutes are also driving the demand for these products. However, the high cost involved with these treatments coupled with a lack of skilled surgeons may hamper this market`s growth rate over the forecast period.
The increasing number of orthopedic surgeries. Rising geriatric population base. Increasing prevalence of chronic musculoskeletal disorders. Growing awareness about advanced treatment procedures such as autologous and allogenic bone grafting. Presence of favorable reimbursement policies in the public healthcare system.
Despite this challenging environment, there are still some opportunities that exist in the Kazakhstan bone grafts and substitutes market. Companies may look into providing alternative delivery channels such as telemedicine services or home care services which allow doctors to provide safe treatments without direct patient contact while keeping social distancing norms intact. Furthermore, companies may consider increasing their production capacity so they can satisfy both domestic needs as well as export demands once normalcy returns after the pandemic has subsided. Increased awareness regarding bone health among people will also help create new opportunities in terms of product innovation or expansion into untapped markets within Kazakhstan itself or abroad
The major players operating in Kazakhstan???s Bone Grafts & Substitutes Market include Stryker Corporation; Zimmer Biomet Holdings Inc.; DePuy Synthes Companies; Integra LifeSciences Holding Corporation; Medtronic plc.; Exactech Inc., Wright Medical Group N.V.; Orthofix International NV; NuVasive Inc.; RTI Surgical Holdings Inc., and others.
The Covid-19 pandemic has had a significant impact on the Kazakhstan bone grafts and substitutes market, resulting in a decrease in sales and demand for these products. The disruption of global supply chains due to travel restrictions, lockdowns, and other safety measures has caused delays in manufacturing, thus impacting the availability of raw materials needed to produce bone grafts and substitutes. Additionally, the decreased number of elective surgeries due to healthcare facilities prioritizing treating Covid-19 patients has also contributed to lower demand for these products. Furthermore, economic instability caused by the pandemic has resulted in budget cuts within many hospitals across Kazakhstan???reducing their capacity to purchase costly bone grafts and substitutes. All these factors have led to an overall decline in revenues from this sector over 2020.